Examkin

Soru

Zorluk: OrtaGynecologic Oncology

A 67-year-old woman, gravida 1, para 1, presents to her gynecologist with a recent episode of painless vaginal bleeding. She reached menopause at age 53. Her past medical history is significant for type 2 diabetes mellitus, chronic hypertension, and obesity (BMI 41 kg/m241 \text{ kg/m}^2). Pelvic examination is unremarkable, and there is no active bleeding from the cervical os. Transvaginal ultrasonography is performed and demonstrates a 14-mm14\text{-mm} thickened, heterogeneous endometrial stripe. Arrange the following steps in the most appropriate chronological order for her comprehensive evaluation and definitive management.

  1. 1Perform an outpatient endometrial biopsy to establish a histologic diagnosis.
  2. 2Perform a total extrafascial hysterectomy with bilateral salpingo-oophorectomy and surgical staging.
  3. 3Administer adjuvant vaginal cuff brachytherapy based on intermediate-risk surgical pathology.
  4. 4Initiate long-term clinical surveillance with regular speculum and pelvic examinations.

Cevap

The correct sequence begins with diagnostic tissue sampling (endometrial biopsy), followed by primary surgical treatment and staging (hysterectomy with salpingo-oophorectomy), then postoperative risk-based adjuvant treatment (brachytherapy), and finally, long-term postoperative monitoring (clinical surveillance).
The standard of care for a postmenopausal woman with abnormal bleeding and a thickened endometrial stripe (>4 mm>4\text{ mm}) is to first obtain a tissue diagnosis via endometrial biopsy. Once endometrioid adenocarcinoma is confirmed, the definitive primary treatment is surgical (total extrafascial hysterectomy with bilateral salpingo-oophorectomy and lymph node evaluation). Adjuvant radiation, such as vaginal brachytherapy, is only administered after surgery if the final pathology report indicates an increased risk of local recurrence. Finally, after all active treatments are completed, the patient enters a long-term clinical surveillance phase.

Adım Adım Çözüm

1
Endometrial Biopsy
Histologic diagnosis of endometrial carcinoma.
Required to definitively confirm malignancy in a patient with postmenopausal bleeding and a thickened endometrial stripe prior to undertaking any invasive surgical procedures.
2
Hysterectomy and Surgical Staging
Removal of the primary tumor and assessment of lymph nodes.
Serves as both the definitive primary treatment and the mechanism to determine the exact surgical stage and risk profile of the cancer.
3
Adjuvant Vaginal Brachytherapy
Eradication of microscopic residual disease in the vaginal vault.
Reduces the risk of local recurrence in patients identified postoperatively as having intermediate-risk features (e.g., greater than 50% myometrial invasion).
4
Clinical Surveillance
Ongoing postoperative monitoring.
Allows for the early detection of vaginal vault recurrences, which can often be successfully salvaged if identified promptly.

Anahtar Kavram

The chronological management pathway for endometrial carcinoma involves initial histologic diagnosis, followed by surgical staging, risk-stratified adjuvant therapy, and long-term clinical surveillance.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru